Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 128 results for "Cellular Therapy (CT)".

Thumbnail for Psychiatric Manifestations of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy in Hematologic Malignancies: A Systematic Review and Meta-Analysis

CT - 328

Psychiatric Manifestations of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy in Hematologic Malignancies: A Systematic Review and Meta-Analysis

Anwesha Gupta

Poster Presenter: Anwesha Gupta

Thumbnail for Real-World Treatment Patterns, Chimeric Antigen Receptor (CAR) T Cell Therapy Referral Barriers, and Time-to-Next Treatment (TTNT) in Patients With Third-Line or Later (3L+) Follicular Lymphoma (FL) Who Experienced Progression =24 Months of First-Line Chemoimmunotherapy (POD24): a United States (US) Claims Analysis

CT - 341

Real-World Treatment Patterns, Chimeric Antigen Receptor (CAR) T Cell Therapy Referral Barriers, and Time-to-Next Treatment (TTNT) in Patients With Third-Line or Later (3L+) Follicular Lymphoma (FL) Who Experienced Progression =24 Months of First-Line Chemoimmunotherapy (POD24): a United States (US) Claims Analysis

Previous 1...7 8 9 10 11 12 13...15 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Sairah Ahmed

Poster Presenter: Sairah Ahmed

Thumbnail for Real-World ICU Utilization and Hematologic Toxicities Following CAR-T Therapy in Diffuse Large B-Cell Lymphoma

CT - 379

Real-World ICU Utilization and Hematologic Toxicities Following CAR-T Therapy in Diffuse Large B-Cell Lymphoma

Nayanika Tummala

Poster Presenter: Nayanika Tummala

Thumbnail for Impact of Chronic Kidney Disease on Outcomes Following CAR-T Therapy: A Propensity-Matched Real-World Analysis

CT - 382

Impact of Chronic Kidney Disease on Outcomes Following CAR-T Therapy: A Propensity-Matched Real-World Analysis

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Higher Early-Posttransplant Tacrolimus Levels Are Associated With Inferior Survival Outcomes After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

CT - 385

Higher Early-Posttransplant Tacrolimus Levels Are Associated With Inferior Survival Outcomes After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Hien Lau

Poster Presenter: Hien Lau

$Thumbnail for CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory B-Cell Malignancies: Response Rates, Durability, and Toxicity$

CT - 413

CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory B-Cell Malignancies: Response Rates, Durability, and Toxicity

Hiam Ghunaim

Poster Presenter: Hiam Ghunaim

Thumbnail for Cost-Effective Analysis of Teclistamab and Daratumumab vs Ciltacabtagene Autoleucel in Relapsed Multiple Myeloma

CT - 422

Cost-Effective Analysis of Teclistamab and Daratumumab vs Ciltacabtagene Autoleucel in Relapsed Multiple Myeloma

Muhammad Bilal Abid

Poster Presenter: Muhammad Bilal Abid

Thumbnail for Extracellular Vesicles in Autologous Serum Eye Drops Display Distinct Immunoregulatory Signatures in Ocular Chronic Graft-Versus-Host Disease

CT - 430

Extracellular Vesicles in Autologous Serum Eye Drops Display Distinct Immunoregulatory Signatures in Ocular Chronic Graft-Versus-Host Disease

Rachel Crossland

Poster Presenter: Rachel Crossland

Thumbnail for Outcome of Allogeneic Bone Marrow Transplantation in Benign Conditions-A Single-Center Experience From Gambat Institute of Medical Sciences

CT - 440

Outcome of Allogeneic Bone Marrow Transplantation in Benign Conditions-A Single-Center Experience From Gambat Institute of Medical Sciences

Uzair Ahmad

Poster Presenter: Uzair Ahmad

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors